BioCentury
ARTICLE | Financial News

Arsanis completes venture financing

April 28, 2017 5:56 PM UTC

On April 26, infectious disease company Arsanis Inc. (Waltham, Mass.) raised $45.5 million in a series D round led by new investor the Bill & Melinda Gates Foundation (Seattle. Wash.). Also participating were new investors GV and Alexandria Venture Investments. Existing investors OrbiMed, Polaris Venture Partners, SV Health Investors, NeoMed, EMBL Ventures and the Anna Maria and Stephen Keller Foundation also participated...